Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China

Shiwen Wang, Tongzhan Wang, Wenqiang Zhang, Xiaolin Liu, Xiaofang Wang, Haiyan Wang, Xiaozhou He, Shunxian Zhang, Shuhui Xu, Yang Yu, Xingbing Jia, Maolin Wang, Aiqiang Xu, Wei Ma, Minal M Amin, Stephanie R Bialek, Sheila C Dollard, Chengbin Wang, Shiwen Wang, Tongzhan Wang, Wenqiang Zhang, Xiaolin Liu, Xiaofang Wang, Haiyan Wang, Xiaozhou He, Shunxian Zhang, Shuhui Xu, Yang Yu, Xingbing Jia, Maolin Wang, Aiqiang Xu, Wei Ma, Minal M Amin, Stephanie R Bialek, Sheila C Dollard, Chengbin Wang

Abstract

Congenital cytomegalovirus (CMV) infection is the leading viral cause of birth defects and developmental disabilities in developed countries. However, CMV seroprevalence and burden of congenital CMV infection are not well defined in China.Cohort of newborns from 5 birthing hospitals in 2 counties of Shandong Province, China, were enrolled from March 2011 to August 2013. Dried blood spots (DBS) and saliva were collected within 4 days after birth for IgG testing for maternal seroprevalence and real-time PCR testing for congenital CMV infection, respectively.Among 5020 newborns tested for CMV IgG, 4827 were seropositive, resulting in CMV maternal seroprevalence of 96.2% (95% confidence interval [CI]:95.6%-96.7%). Of the 10,933 newborns screened for congenital CMV infection, 75 had CMV detected, resulting in an overall prevalence of 0.7% (95% CI: 0.5%-0.9%), with prevalences of 0.4% (14/3995), 0.6% (66/10,857), and 0.7% (52/7761) for DBS, wet saliva, and dried saliva specimens screened, respectively. Prevalence of congenital CMV infection decreased with increasing maternal age (0.9%, 0.6%, and 0.3% among newborns delivered from mothers aged 16-25, 26-35, and >35 years, respectively; P = 0.03), and was higher among preterm infants than full term infants (1.3% vs 0.6%, P = 0.04), infants with intrauterine growth restriction (IUGR) than those without (1.8% vs 0.7%, P = 0.03), and twins or triplets than singleton pregnancies (2.8% vs 0.7%, P = 0.04). None of the 75 newborns exhibited symptomatic congenital CMV infection, and there was no difference in clinical characteristics and newborn hearing screening results between infants with and without congenital CMV infection at birth.Congenital CMV infection prevalence was lower and the clinical manifestations were milder in this relatively developed region of China compared to populations from other countries with similarly high maternal seroprevalence. Follow-up on children with congenital CMV infection will clarify the burden of disabilities from congenital CMV infection in China.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Geographic location of the study sites (Wendeng and Pingyin Counties) of Shandong Province in China.

References

    1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253–76.
    1. Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663–7.
    1. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005;5:70.
    1. Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis 2010;50:1439–47.
    1. Basha J, Iwasenko JM, Robertson P, et al. Congenital cytomegalovirus infection is associated with high maternal socio-economic status and corresponding low maternal cytomegalovirus seropositivity. J Paediatr Child Health 2014;50:368–72.
    1. Taniguchi K, Watanabe N, Sato A, et al. Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study. J Clin Virol 2014;59:192–4.
    1. Ludwig A, Hengel H. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill 2009;14:26–32.
    1. Lanzieri TM, Dollard SC, Bialek SR, et al. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis 2014;22:44–8.
    1. Manicklal S, Emery VC, Lazzarotto T, et al. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013;26:86–102.
    1. Wang C, Zhang X, Bialek S, et al. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011;52:e11–3.
    1. Mussi-Pinhata MM, Yamamoto AY, Moura Brito RM, et al. Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population. Clin Infect Dis 2009;49:522–8.
    1. Qi Y, Feng Z, Cai X, et al. Human cytomegalovirus infection status among reproductive aged women and hospitalized children in china. The 5th International Congenital CMV Conference 2015. Brisbane, Australia.
    1. Papageorghiou AT, Ohuma EO, Altman DG, et al. Newborn Growth Consortium for the 21st C. International standards for fetal growth based on serial ultrasound measurements: the fetal growth longitudinal study of the intergrowth-21st project. Lancet 2014;384:869–79.
    1. Fu J, Yu M. A hospital-based birth weight analysis using computerized perinatal data base for a Chinese population. J Matern Fetal Neonatal Med 2011;24:614–8.
    1. Koontz D, Baecher K, Amin M, et al. Evaluation of DNA extraction methods for the detection of cytomegalovirus in dried blood spots. J Clin Virol 2015;66:95–9.
    1. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857–72.
    1. Kharrazi M, Hyde T, Young S, et al. Use of screening dried blood spots for estimation of prevalence, risk factors, and birth outcomes of congenital cytomegalovirus infection. J Pediatr 2010;157:191–7.
    1. Xu F, Zhang S, Zhang Y, et al. A study on cytomegalovirus infection in mothers and infants of Beijing. Chin J Perinat Med 2012;15:459–61.
    1. Zhang S, Hu L, Chen J, et al. Cytomegalovirus seroprevalence in pregnant women and association with adverse pregnancy/neonatal outcomes in Jiangsu Province, China. PLoS One 2014;9:e107645.
    1. Wen L, Wu S, Lu S. [The epidemiological study on human cytomegalovirus infection of pregnant women and the maternal-fetal transmission in three Chinese metropolis]. Zhonghua Fu Chan Ke Za Zhi 1996;31:714–7.
    1. Ornoy A, Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006;21:399–409.
    1. Sahiner F, Cekmez F, Cetinkaya M, et al. Congenital cytomegalovirus infections and glycoprotein b genotypes in live-born infants: a prevalence study in turkey. Infect Dis (Lond) 2015;47:465–71.
    1. Yinon Y, Yagel S, Tepperberg-Dikawa M, et al. Prenatal diagnosis and outcome of congenital cytomegalovirus infection in twin pregnancies. BJOG 2006;113:295–300.
    1. Souza MA, Passos AM, Treitinger A, et al. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil. Rev Soc Bras Med Trop 2010;43:359–61.
    1. Yamamoto AY, Anastasio AR, Reis AC, et al. Contribution of congenital cmv infection to hearing loss at birth in a highly cmv seropositive maternal population. The 5th International Congenital CMV Conference and 15th International CMV/Beta Herpes Virus Workshop. 2015.
    1. Li L, Zhao L, Li Y, et al. Prevalence of congenital cytomegalovirus infection in Beijing. Chin J Neonatol 2012;27:5–9.
    1. Boppana SB, Ross SA, Novak Z, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 2010;303:1375–82.
    1. Forner G, Abate D, Mengoli C, et al. High cytomegalovirus (CMV) dnaemia predicts CMV sequelae in asymptomatic congenitally infected newborns born to women with primary infection during pregnancy. J Infect Dis 2015;212:67–71.
    1. Yamamoto AY, Mussi-Pinhata MM, Marin LJ, et al. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol 2006;36:228–30.
    1. Boppana SB, Fowler KB, Pass RF, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005;146:817–23.
    1. Leruez-Ville M, Vauloup-Fellous C, Couderc S, et al. Prospective identification of congenital cytomegalovirus infection in newborns using real-time polymerase chain reaction assays in dried blood spots. Clin Infect Dis 2011;52:575–81.
    1. Zhang XW, Li F, Yu XW, et al. Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J Clin Virol 2007;40:180–5.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa